Coppola, L.; Baselice, S.; Messina, F.; Giannatiempo, R.; Farina, A.; Vitagliano, L.; Smaldone, G.; Salvatore, M.
KCTD15 Is Overexpressed in her2+ Positive Breast Cancer Patients and Its Silencing Attenuates Proliferation in SKBR3 CELL LINE. Diagnostics 2022, 12, 591.
https://doi.org/10.3390/diagnostics12030591
AMA Style
Coppola L, Baselice S, Messina F, Giannatiempo R, Farina A, Vitagliano L, Smaldone G, Salvatore M.
KCTD15 Is Overexpressed in her2+ Positive Breast Cancer Patients and Its Silencing Attenuates Proliferation in SKBR3 CELL LINE. Diagnostics. 2022; 12(3):591.
https://doi.org/10.3390/diagnostics12030591
Chicago/Turabian Style
Coppola, Luigi, Simona Baselice, Francesco Messina, Rosa Giannatiempo, Amalia Farina, Luigi Vitagliano, Giovanni Smaldone, and Marco Salvatore.
2022. "KCTD15 Is Overexpressed in her2+ Positive Breast Cancer Patients and Its Silencing Attenuates Proliferation in SKBR3 CELL LINE" Diagnostics 12, no. 3: 591.
https://doi.org/10.3390/diagnostics12030591
APA Style
Coppola, L., Baselice, S., Messina, F., Giannatiempo, R., Farina, A., Vitagliano, L., Smaldone, G., & Salvatore, M.
(2022). KCTD15 Is Overexpressed in her2+ Positive Breast Cancer Patients and Its Silencing Attenuates Proliferation in SKBR3 CELL LINE. Diagnostics, 12(3), 591.
https://doi.org/10.3390/diagnostics12030591